Tuskegee Legacy Discourages Trial Participation by Blacks

Simple item page
dc.contributor.authorGever, John
dc.date.accessioned2019-08-14T15:00:49Z
dc.date.available2019-08-14T15:00:49Z
dc.date.issued2008
dc.description.abstractAfrican Americans are still suspicious of the clinical research establishment, some 35 years after details of the infamous Tuskegee study of untreated syphilis were revealed, researchers here said. More than twice as many blacks as white believe physicians secretly experiment on patients, reported Neil R. Powe, M.D., M.P.H., and colleagues at Johns Hopkins in the January issue of Medicine. The researchers said this was the first study to quantify different perceptions of risk associated with clinical trials by race. They wanted to explore the difficulty noted by many earlier researchers in enrolling African-American participants in clinical trials.
dc.description.urihttps://www.medpagetoday.com/sso-token.php?redirecturl=https%3A%2F%2Fwww.medpagetoday.org%2Fpublichealthpolicy%2Fclinicaltrials%2F7952
dc.identifierhttps://doi.org/10.13016/uwbi-b3wq
dc.identifier.citationGever, John (2008) Tuskegee Legacy Discourages Trial Participation by Blacks. UNSPECIFIED.
dc.identifier.otherEprint ID 898
dc.identifier.urihttp://hdl.handle.net/1903/22859
dc.subjectBioethics
dc.subjectResearch
dc.subjectstudies
dc.subjectAfrican Americans
dc.subjectclinical research establishment
dc.subjectTuskegee study
dc.subjectsyphilis
dc.subjectclinical trials
dc.titleTuskegee Legacy Discourages Trial Participation by Blacks
dc.typeOther

Files

Collections

Minority Health and Health Equity Archive